Key points are not available for this paper at this time.
Lactoferrin (LF) has been shown to be effective in attenuating some aging-related changes, although its potential in alleviating aging-related cognitive decline remains to be clarified. In this study, we evaluated the effects of LF (2000 mg/kg/day for 3 months) on the cognitive ability of 16-month-old C57/BL6J mice. Spatial cognition was improved in aged mice after LF administration, with more pyramidal cells detected in the hippocampi, and more regular distribution. LF also reduced iron deposition, malondialdehyde (MDA) and ROS levels in the hippocampus. Similarly, LF decreased the expression of two subunits of NAPDH oxidase: Gp91phox and P22phox, and reduced hippocampal and serum levels of IL-1β, IL-6 and TNF-α in aged mice. Metabolomic analysis revealed alterations in LysoPG, LysoPS, xanthine, adenosine and oxypurinol, which were partially reversed by LF. The potential of LF to protect cognitive function in aged animals offers a unique pharmacological approach for neurodegenerative disorders associated with aging.
Zheng et al. (2019) studied this question.